Journal article
Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States
Abstract
Purpose: Few studies have examined how the absolute risk of thromboembolism with COVID-19 has evolved over time across different countries. Researchers from the European Medicines Agency, Health Canada, and the United States (US) Food and Drug Administration established a collaboration to evaluate the absolute risk of arterial (ATE) and venous thromboembolism (VTE) in the 90 days after diagnosis of COVID-19 in the ambulatory (eg, outpatient, …
Authors
Re VL; Cocoros NM; Hubbard RA; Dutcher SK; Newcomb CW; Connolly JG; Perez-Vilar S; Carbonari DM; Kempner ME; Hernández-Muñoz JJ
Journal
Clinical Epidemiology, Vol. 16, No. 0, pp. 0–0
Publisher
Taylor & Francis
Publication Date
December 31, 2025
DOI
10.2147/clep.s448980
ISSN
1179-1349